OpenVSafe by OpenVAERS
Search V-safe

EU7-14550-99625

4 vaccinations 9 coded responses 54 check-ins 8 free-text entries 4 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
773 / TX
Registered
2021-01-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-24
    Dose 1 — Moderna
  2. 2021-01-25
    Registered in v-safe
  3. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-31
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-14
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-21
    Dose 2 — Moderna
  13. 2021-02-21
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness · Chills, Headache · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness · Headache
    Adult check-in
  16. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-28
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  21. 2021-03-07
    Survey response — day 14, dose 2
    MedDRA: Conjunctivitis, Vision blurred — Feeling: Good · Be unable to do your normal daily activities
    Free text: Worsening conjunctivitis and blurry vision.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-14
    Survey response — day 21, dose 2
    MedDRA: Conjunctivitis — Feeling: Good · Be unable to do your normal daily activities
    Free text: conjunctivitis (may be due to allergies)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-03-21
    Survey response — day 28, dose 2
    MedDRA: Conjunctivitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: conjunctivitis (possibly due to allergies)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-03-21
    Report sent to call center — day 28, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-03-28
    Survey response — day 35, dose 2
    MedDRA: Conjunctivitis, Seasonal allergy — Feeling: Good
    Free text: Conjunctivitis (likely due to seasonal allergies)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-04-04
    Survey response — day 42, dose 2
    MedDRA: Conjunctivitis — Feeling: Good · Be unable to do your normal daily activities
    Free text: conjunctivitis (continues worsening, probably due to seasonal allergies)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-05-23
    Survey response — 3 months, dose 2
    MedDRA: Autoimmune disorder, Eye inflammation, Uveitis — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Panuveitis (actually started 2 weeks after 1st dose, but only recently diagnosed), a serious inflammation of both eyes. Autoimmune condition, which I am wondering if it could be associated with the vaccination.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  28. 2021-05-23
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-08-23
    Survey response — 6 months, dose 2
    MedDRA: Pulmonary embolism — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    Free text: Pulmonary embolisms
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  30. 2021-08-23
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  31. 2021-08-25
  32. 2021-08-27
  33. 2021-08-30
    Call successful
    Participant prefers to complete VAERS report online
  34. 2021-10-28
    Dose 3 — Moderna
  35. 2021-10-28
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  37. 2021-10-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  38. 2021-10-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  39. 2021-11-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  40. 2021-11-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  41. 2021-11-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  42. 2021-11-04
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  43. 2021-11-11
    Survey response — day 14, dose 3
    MedDRA: Migraine — Feeling: Fair
    Free text: Migraine headaches
    MedDRA releases: 2024-11 · check-in free text available
  44. 2021-11-18
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  45. 2021-11-25
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  46. 2021-12-02
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  47. 2021-12-09
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  48. 2022-01-27
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  49. 2022-04-05
    Dose 4 — Moderna
  50. 2022-04-05
    Health check-in — day 0, dose 4
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  51. 2022-04-06
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  52. 2022-04-07
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Headache
    Adult check-in
  53. 2022-04-08
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  54. 2022-04-09
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  55. 2022-04-10
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Muscle or body aches
    Adult check-in
  56. 2022-04-11
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  57. 2022-04-12
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  58. 2022-04-19
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  59. 2022-04-26
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  60. 2022-05-05
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  61. 2022-05-12
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  62. 2022-05-17
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  63. 2022-07-05
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  64. 2022-10-04
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  65. 2023-04-05
    Survey response — 12 months, dose 4
    MedDRA: Blindness, Macular degeneration, Macular oedema, Office visit, Pain, Visual impairment, Vitreous floaters — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  66. 2023-04-05
    Report sent to call center — 12 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  67. 2023-04-06
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-01-24Moderna
22021-02-21Moderna
32021-10-28Moderna No
42022-04-05Moderna No

Call center

4 call center cases

4 successful

See the call center timeline

Free text

Release 5 — day 14, dose 2

2021-03-07

Symptoms: Worsening conjunctivitis and blurry vision.

Release 5 — day 21, dose 2

2021-03-14

Symptoms: conjunctivitis (may be due to allergies)

Release 6 — day 28, dose 2

2021-03-21

Symptoms: conjunctivitis (possibly due to allergies)

Release 6 — day 35, dose 2

2021-03-28

Symptoms: Conjunctivitis (likely due to seasonal allergies)

Release 6 — day 42, dose 2

2021-04-04

Symptoms: conjunctivitis (continues worsening, probably due to seasonal allergies)

Release 8 — 3 months, dose 2

2021-05-23

Symptoms: Panuveitis (actually started 2 weeks after 1st dose, but only recently diagnosed), a serious inflammation of both eyes. Autoimmune condition, which I am wondering if it could be associated with the vaccination.

Release 9 — 6 months, dose 2

2021-08-23

Symptoms: Pulmonary embolisms

Release 10 — day 14, dose 3

2021-11-11

Symptoms: Migraine headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDAutoimmune disorder ✓ ✓ ✓
SDBlindness · · ✓
SDConjunctivitis ✓ ✓ ✓
SDEye inflammation ✓ ✓ ✓
SDMacular degeneration · · ✓
SDMacular oedema · · ✓
SDMigraine · · ✓
SDPain · · ✓
SDPulmonary embolism ✓ · ✓
SDSeasonal allergy ✓ ✓ ✓
SDUveitis ✓ ✓ ✓
SDVision blurred ✓ ✓ ✓
SDVisual impairment · · ✓
SDVitreous floaters · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release